Publication | Closed Access
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX? adjuvant in women with cervical intraepithelial neoplasia
173
Citations
19
References
2004
Year
Hpv16-specific ImmunotherapyCervical CancerHuman Papillomavirus VaccinesImmunologyPathologyE6e7 Fusion ProteinPublic HealthImmunotherapyMedicineViral OncologyPhase 1Precancerous LesionsCancer-associated Virus
| Year | Citations | |
|---|---|---|
Page 1
Page 1